Surgical management of metastatic melanoma in the era of targeted systemic therapies.

D Peter O'Leary, Kevin G Byrnes, Derek G Power, H Paul Redmond
Author Information
  1. D Peter O'Leary: Department of Surgery, Cork University Hospital, Cork, Ireland.

Abstract

Treatment strategies for metastatic melanoma have changed markedly in recent times due to the advent of targeted systemic therapies. In addition to these developments, surgery remains a useful adjunct that can confer survival benefits in selected patients. In this review, we examine the current literature to highlight the role of surgical intervention in metastatic melanoma in the era of targeted systemic therapies.

MeSH Term

Antibodies, Monoclonal
Combined Modality Therapy
Gene Expression Regulation, Neoplastic
Humans
Medical Oncology
Melanoma
Mitosis
Molecular Targeted Therapy
Neoplasm Metastasis
Perfusion
Skin Neoplasms
Treatment Outcome

Chemicals

Antibodies, Monoclonal

Word Cloud

Created with Highcharts 10.0.0metastaticmelanomatargetedsystemictherapieseraTreatmentstrategieschangedmarkedlyrecenttimesdueadventadditiondevelopmentssurgeryremainsusefuladjunctcanconfersurvivalbenefitsselectedpatientsreviewexaminecurrentliteraturehighlightrolesurgicalinterventionSurgicalmanagement

Similar Articles

Cited By (1)